The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Wednesday, February 28, 2024
PulseSight Therapeutics SAS, an ophthalmology biotech company developing disruptive non-viral gene therapies with minimally-invasive delivery ...
read more
Friday, February 23, 2024
AbbVie Inc. and Tentarix Biotherapeutics announced a multi-year collaboration focused on the discovery and development of conditionally-active, multi-...
read more
Thursday, February 22, 2024
AstraZeneca announced the successful completion of the acquisition of Gracell Biotechnologies Inc., a global clinical-stage biopharmaceutical company ...
read more
Tuesday, February 20, 2024
The FDA approved Amtagvi, the first cellular therapy indicated for the treatment of adult patients with a type of skin cancer (melanoma) that is ...
read more
Friday, February 16, 2024
Astellas Pharma Inc. and Kelonia Therapeutics announced that Xyphos Biosciences, Inc., (a wholly owned subsidiary of Astellas) and Kelonia have ...
read more
Wednesday, February 14, 2024
Alys Pharmaceuticals, Inc., an immuno-dermatology focused company, launches with an R&D pipeline enabled by multiple platform technologies and a $100 ...
read more
Wednesday, February 14, 2024
AbbVie announced that it has completed its acquisition of ImmunoGen. With the completion of the acquisition, ImmunoGen is now part of AbbVie.
read more
Friday, February 09, 2024
BioNTech SE and Autolus Therapeutics plc announced a strategic collaboration aimed at advancing both companies’ autologous CAR-T programs towards ...
read more
Tuesday, February 06, 2024
AstraZeneca is investing $300 million in a state-of-the-art facility in Rockville, MD to launch its life-saving cell therapy platforms in the US for ...
read more
Tuesday, February 06, 2024
CEL-SCI Corporation announced that its Multikine® (Leukocyte Interleukin, Injection)* cGMP state-of-the-art dedicated manufacturing facility ...
read more
Bristol Myers Squibb announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended ...
read more
Tuesday, January 16, 2024
PolTREG S.A. announced it received a Notice of Allowance from the United States Patent and Trademark Office (USPTO), covering the manufacturing of T-...
read more
Thursday, January 11, 2024
Factor Bioscience Inc. announced the award of a U.S. Department of Defense grant to develop next-generation cell therapy candidates using Factor's ...
read more
Thursday, January 11, 2024
Adimab, LLC, a provider of fully human monoclonal and multispecific antibodies, announced that it is nearing completion of adding more than 50,000 ...
read more
Wednesday, January 10, 2024
The Novo Nordisk Foundation is committing up to $25 million to support the early-stage development of innovative tools to prevent, diagnose and treat ...
read more